DE2500076C3 - Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen - Google Patents
Verfahren zur Gewinnung von intravenös-verträglichen GammaglobulinenInfo
- Publication number
- DE2500076C3 DE2500076C3 DE2500076A DE2500076A DE2500076C3 DE 2500076 C3 DE2500076 C3 DE 2500076C3 DE 2500076 A DE2500076 A DE 2500076A DE 2500076 A DE2500076 A DE 2500076A DE 2500076 C3 DE2500076 C3 DE 2500076C3
- Authority
- DE
- Germany
- Prior art keywords
- gamma globulin
- precipitate
- gamma
- solution
- precipitation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2500076A DE2500076C3 (de) | 1975-01-02 | 1975-01-02 | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
| NLAANVRAGE7514627,A NL179824C (nl) | 1975-01-02 | 1975-12-16 | Werkwijze voor het winnen van intraveneus verdraagbare gammaglobulinen. |
| SE7514388A SE437470B (sv) | 1975-01-02 | 1975-12-18 | Forfarande for utvinning av ett rent gammaglobulinpreparat, som tolereras vid intravenos administrering |
| DK584375A DK144679C (da) | 1975-01-02 | 1975-12-22 | Fremgangsmaade til udvinding af intravenoeskompatible gammaglobuliner |
| AT981675A AT344883B (de) | 1975-01-02 | 1975-12-23 | Verfahren zur gewinnung von intravenoesvertraeglichem gammaglobulin |
| FR7539814A FR2296429A1 (fr) | 1975-01-02 | 1975-12-26 | Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline |
| JP15974275A JPS5512001B2 (en) | 1975-01-02 | 1975-12-27 | Improving the compatibility of gamma globulins |
| GB53020/75A GB1495159A (en) | 1975-01-02 | 1975-12-29 | Process reducing the anticomplementary activity of gamma globulins |
| DD190614A DD121875A5 (US08088816-20120103-C00036.png) | 1975-01-02 | 1975-12-29 | |
| IE2826/75A IE43449B1 (en) | 1975-01-02 | 1975-12-30 | Process reducing the anticomplementary activity of gamma globulins |
| EG775/75A EG11987A (en) | 1975-01-02 | 1975-12-30 | Process of improving the compatibility of gamma globulins |
| ZA00758050A ZA758050B (en) | 1975-01-02 | 1975-12-30 | Process of improving the compatibility of gamma globulins |
| ES443982A ES443982A1 (es) | 1975-01-02 | 1975-12-30 | Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos. |
| IL48766A IL48766A (en) | 1975-01-02 | 1975-12-30 | Process for obtaining intravenous-compatible gamma globulin |
| IN2413/CAL/75A IN143525B (US08088816-20120103-C00036.png) | 1975-01-02 | 1975-12-30 | |
| BE6045314A BE837211A (fr) | 1975-01-02 | 1975-12-30 | Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline |
| AU87921/75A AU505416B2 (en) | 1975-01-02 | 1975-12-30 | Improving the compatibility of gamma globulins |
| CA242,734A CA1058075A (en) | 1975-01-02 | 1975-12-30 | Process of improving the compatibility of gamma globulins |
| SU7502306354A SU576898A3 (ru) | 1975-01-02 | 1975-12-31 | Способ снижени реактогенности гамма-глобулина |
| PL1976186289A PL99599B1 (pl) | 1975-01-02 | 1976-01-01 | Sposob otrzymywania tolerowanej srodzylnie gammaglobuliny |
| MX663076U MX5052E (es) | 1975-01-02 | 1976-01-05 | Procedimiento para preparar gamma globulinas iv compatibles |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2500076A DE2500076C3 (de) | 1975-01-02 | 1975-01-02 | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2500076A1 DE2500076A1 (de) | 1976-07-08 |
| DE2500076B2 DE2500076B2 (de) | 1979-02-22 |
| DE2500076C3 true DE2500076C3 (de) | 1982-11-18 |
Family
ID=5935911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2500076A Expired DE2500076C3 (de) | 1975-01-02 | 1975-01-02 | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
Country Status (20)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2604759C2 (de) * | 1976-02-07 | 1983-06-01 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von iv-verträglichen Γglobulinen |
| JPS6016406B2 (ja) * | 1976-08-06 | 1985-04-25 | マイヤ−、ル−イス、コ−バル | 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン |
| US4124576A (en) * | 1976-12-03 | 1978-11-07 | Coval M L | Method of producing intravenously injectable gamma globulin |
| GB1603244A (en) * | 1977-05-20 | 1981-11-18 | Max Planck Gesellschaft | Medicaments for the suppression of pathological processes |
| JPS5822085B2 (ja) * | 1977-07-19 | 1983-05-06 | 株式会社ミドリ十字 | 静注用ガンマ・グロブリン製剤 |
| AT359641B (de) * | 1978-09-19 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates |
| EP0019403B1 (en) * | 1979-05-10 | 1985-07-31 | American Hospital Supply Corporation | Hydroxyalkyl-starch drug carrier |
| US4396608A (en) * | 1981-08-24 | 1983-08-02 | Cutter Laboratories | Intravenously injectable immune serum globulin |
| DE3271181D1 (en) * | 1982-02-08 | 1986-06-19 | Schweiz Serum & Impfinst | Intravenously administrable human immunoglobuline and process for its preparation |
| US4482483A (en) * | 1983-04-06 | 1984-11-13 | Armour Pharmceutical Company | Composition of intravenous immune globulin |
| SE8302483L (sv) * | 1983-05-02 | 1984-11-03 | Pharmacia Ind | Forfarande vid rening av biologiskt aktiva substanser |
| US5945098A (en) * | 1990-02-01 | 1999-08-31 | Baxter International Inc. | Stable intravenously-administrable immune globulin preparation |
| DE19907257A1 (de) * | 1999-02-21 | 2000-09-14 | Bernd Horst Meier | Mittel zur Steuerung der Diffusion von Injektionslösungen |
| DE10040707A1 (de) * | 2000-08-17 | 2002-03-14 | Braun Melsungen Ag | Kolloidale Pharmakomodulation injizierter Arzneimittel |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| CA2631195C (en) | 2005-11-30 | 2016-04-05 | Abbott Laboratories | Monoclonal antibodies against amyloid beta protein and uses thereof |
| CN101432302A (zh) | 2005-11-30 | 2009-05-13 | 艾博特公司 | 抗－Aβ球聚体抗体，其抗原结合部分，相应的杂交瘤、核酸、载体、宿主细胞，生产所述抗体的方法，包含所述抗体的组合物，所述抗体的应用以及使用所述抗体的方法 |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| EP2124952A2 (en) | 2007-02-27 | 2009-12-02 | Abbott GmbH & Co. KG | Method for the treatment of amyloidoses |
| US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| MX358739B (es) | 2010-08-14 | 2018-09-03 | Abbvie Inc Star | Proteinas de union a amiloide beta. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE348942B (US08088816-20120103-C00036.png) * | 1970-06-02 | 1972-09-18 | Statens Bakteriologiska Labor | |
| DE2234069A1 (de) * | 1971-07-16 | 1973-02-08 | South African Inventions | Verfahren zur herstellung eines gereinigten gamma-globulins |
| ZA738779B (en) * | 1972-11-27 | 1974-10-30 | Baxter Laboratories Inc | Production of gamma globulin |
| JPS49101516A (US08088816-20120103-C00036.png) * | 1973-01-13 | 1974-09-25 |
-
1975
- 1975-01-02 DE DE2500076A patent/DE2500076C3/de not_active Expired
- 1975-12-16 NL NLAANVRAGE7514627,A patent/NL179824C/xx not_active IP Right Cessation
- 1975-12-18 SE SE7514388A patent/SE437470B/xx not_active IP Right Cessation
- 1975-12-22 DK DK584375A patent/DK144679C/da active
- 1975-12-23 AT AT981675A patent/AT344883B/de active
- 1975-12-26 FR FR7539814A patent/FR2296429A1/fr active Granted
- 1975-12-27 JP JP15974275A patent/JPS5512001B2/ja not_active Expired
- 1975-12-29 GB GB53020/75A patent/GB1495159A/en not_active Expired
- 1975-12-29 DD DD190614A patent/DD121875A5/xx unknown
- 1975-12-30 AU AU87921/75A patent/AU505416B2/en not_active Expired
- 1975-12-30 BE BE6045314A patent/BE837211A/xx not_active IP Right Cessation
- 1975-12-30 IE IE2826/75A patent/IE43449B1/en unknown
- 1975-12-30 EG EG775/75A patent/EG11987A/xx active
- 1975-12-30 ZA ZA00758050A patent/ZA758050B/xx unknown
- 1975-12-30 IL IL48766A patent/IL48766A/xx unknown
- 1975-12-30 IN IN2413/CAL/75A patent/IN143525B/en unknown
- 1975-12-30 CA CA242,734A patent/CA1058075A/en not_active Expired
- 1975-12-30 ES ES443982A patent/ES443982A1/es not_active Expired
- 1975-12-31 SU SU7502306354A patent/SU576898A3/ru active
-
1976
- 1976-01-01 PL PL1976186289A patent/PL99599B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATA981675A (de) | 1977-12-15 |
| FR2296429A1 (fr) | 1976-07-30 |
| ES443982A1 (es) | 1977-07-16 |
| CA1058075A (en) | 1979-07-10 |
| JPS5191321A (en) | 1976-08-10 |
| SE437470B (sv) | 1985-03-04 |
| DK144679B (da) | 1982-05-10 |
| ZA758050B (en) | 1976-12-29 |
| DK584375A (da) | 1976-07-03 |
| DE2500076A1 (de) | 1976-07-08 |
| IL48766A (en) | 1979-11-30 |
| AU8792175A (en) | 1977-07-14 |
| GB1495159A (en) | 1977-12-14 |
| IN143525B (US08088816-20120103-C00036.png) | 1977-12-17 |
| IL48766A0 (en) | 1976-02-29 |
| SE7514388L (sv) | 1976-07-05 |
| PL99599B1 (pl) | 1978-07-31 |
| DD121875A5 (US08088816-20120103-C00036.png) | 1976-09-05 |
| NL179824B (nl) | 1986-06-16 |
| DK144679C (da) | 1982-10-11 |
| FR2296429B1 (US08088816-20120103-C00036.png) | 1978-12-01 |
| NL179824C (nl) | 1986-11-17 |
| SU576898A3 (ru) | 1977-10-15 |
| AU505416B2 (en) | 1979-11-22 |
| NL7514627A (nl) | 1976-07-06 |
| IE43449L (en) | 1976-07-02 |
| BE837211A (fr) | 1976-06-30 |
| DE2500076B2 (de) | 1979-02-22 |
| IE43449B1 (en) | 1981-02-25 |
| EG11987A (en) | 1981-12-31 |
| AT344883B (de) | 1978-08-10 |
| JPS5512001B2 (en) | 1980-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2500076C3 (de) | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen | |
| DE3886134T2 (de) | Polysaccharide, extrahiert aus Pflanzen und verwendet als Medizinen und Zusatzstoffe für Nahrungsmittel. | |
| DE2936047C2 (US08088816-20120103-C00036.png) | ||
| DE2333883C3 (de) | Verfahren zur Herstellung von hochgereinigtem Humanalbumin | |
| DE69012154T2 (de) | Heparinderivate und Verfahren zu ihrer Herstellung. | |
| DE2324717C3 (de) | Verfahren zur Herstellung eines stabilen AHF-Konzentrates (Faktor VIII) | |
| DE2219635C3 (de) | Insulinsalz-Protamin-Komplexe und Verfahren zu ihrer Herstellung | |
| DE3039566A1 (de) | Verfahren zur reinigung von interferon | |
| DE3026180C2 (de) | Rifamycin-SV-Salze von basischen Aminosäuren, Verfahren zu ihrer Herstellung und Arzneimittel zur intraartikulären Injektion bei der Bekämpfung von rheumatoider Arthritis | |
| DE4435392A1 (de) | Hochmolekulare und niedermolekulare Fraktionen des von Willebrand-Faktors | |
| DE2433209A1 (de) | Hitzestabile plasmaproteinloesungen, verfahren zu ihrer herstellung und arzneipraeparate | |
| DE2403994A1 (de) | Herstellung von antisera | |
| DE2837168A1 (de) | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung | |
| DE2835843A1 (de) | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung | |
| DE2604759C2 (de) | Verfahren zur Gewinnung von iv-verträglichen Γglobulinen | |
| DE1940130C2 (de) | Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung | |
| DE2856939A1 (de) | Verfahren zur gewinnung von intravenoes-vertraeglichen gammaglobulinen | |
| CH639394A5 (de) | Verfahren zur herstellung von immunglobulinpraeparationen mit verminderter komplementaktivitaet. | |
| DE1076888B (de) | Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke | |
| DE2415079C3 (de) | Verfahren zum Isolieren von Albumin aus Blutplasma | |
| DE1148037B (de) | Verfahren zur Herstellung eines desaggregierten, das Komplementsystem nicht beeinflussenden Gammaglobulins | |
| DE3034529C2 (de) | Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel | |
| AT271725B (de) | Verfahren zur Gewinnung von Gammaglobulin | |
| DE1767404B2 (de) | Verfahren zur Gewinnung von Lysozym aus einem lysozymhaltigen Ausgangsmaterial | |
| DE1000963C2 (de) | Verfahren zur Herstellung von biologisch aktiven, Vitamine der B-Gruppe enthaltenden Zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OI | Miscellaneous see part 1 | ||
| OI | Miscellaneous see part 1 | ||
| BGA | New person/name/address of the applicant | ||
| AG | Has addition no. |
Ref country code: DE Ref document number: 2604759 Format of ref document f/p: P |
|
| C3 | Grant after two publication steps (3rd publication) | ||
| AG | Has addition no. |
Ref country code: DE Ref document number: 2604759 Format of ref document f/p: P |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: ARMOUR PHARMA GMBH & CO KG, 3440 ESCHWEGE, DE |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: ARMOUR PHARMA GMBH & CO. KG, 4800 BIELEFELD, DE |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: ARMOUR PHARMA GMBH, 3440 ESCHWEGE, DE |
|
| 8339 | Ceased/non-payment of the annual fee |